bf/NASDAQ:XLO_icon.jpeg

NASDAQ:XLO

Xilio Therapeutics, Inc.

  • Stock

USD

Last Close

0.96

26/07 20:00

Market Cap

35.44M

Beta: -

Volume Today

88.76K

Avg: 29.09K

PE Ratio

−0.23

PFCF: −0.25

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-14.82M
-
-20.77M
40.17%
-16.67M
19.76%
-23.18M
39.08%
-16.25M
29.90%
-19.70M
21.23%
-21.35M
8.39%
-24.61M
15.27%
-19.79M
19.60%
-22.47M
13.52%
-22.65M
0.80%
-19.36M
14.53%
-16.75M
13.47%
-17.66M
5.42%
-17.20M
2.56%
depreciation and amortization
316K
-
341K
7.91%
350K
2.64%
373K
6.57%
382K
2.41%
394K
3.14%
440K
11.68%
445K
1.14%
473K
6.29%
489K
3.38%
499K
2.04%
492K
1.40%
460K
6.50%
449K
2.39%
443K
1.34%
deferred income tax
46K
-
-305K
763.04%
15K
104.92%
48K
220.00%
155K
222.92%
4K
97.42%
2K
-
1K
50%
stock based compensation
683K
-
366K
46.41%
794K
116.94%
1.00M
26.20%
1.09M
8.88%
2.07M
89.83%
2.03M
2.03%
2.71M
33.51%
1.87M
30.93%
1.81M
2.99%
1.79M
1.32%
1.80M
0.50%
1.86M
3.39%
1.83M
-
change in working capital
3.28M
-
7.62M
132.72%
-7.26M
195.28%
1.58M
121.78%
-6.14M
488.05%
18K
100.29%
-2.00M
11,233.33%
4.65M
332.04%
-2.52M
154.24%
1.88M
174.54%
-4.92M
361.97%
400K
108.12%
1.03M
158.50%
1.83M
77.27%
4.43M
141.46%
accounts receivables
-30M
-
inventory
accounts payables
597K
-
2.59M
333.50%
-2.84M
209.66%
4.76M
267.69%
-3.55M
174.53%
-1.19M
66.39%
-820K
31.21%
-397K
51.59%
245K
161.71%
1.46M
494.69%
-1.36M
193.21%
-809K
40.43%
542K
167.00%
-438K
180.81%
-304K
30.59%
other working capital
2.68M
-
5.04M
87.98%
-4.43M
187.89%
-3.18M
28.22%
-2.59M
18.41%
1.21M
146.68%
-1.18M
197.85%
5.05M
526.27%
-2.77M
154.82%
423K
115.29%
1.36M
221.04%
1.21M
10.97%
492K
59.31%
2.27M
361.59%
34.73M
1,429.28%
other non cash items
83K
-
-264K
418.07%
53K
120.08%
88K
66.04%
198K
125%
56K
71.72%
53K
5.36%
53K
0%
59K
11.32%
59K
0%
31K
47.46%
87K
180.65%
23K
73.56%
1.95M
8,360.87%
33.02M
1,596.92%
net cash provided by operating activities
-10.46M
-
-12.71M
21.45%
-22.73M
78.94%
-20.14M
11.43%
-20.72M
2.90%
-17.16M
17.17%
-20.84M
21.40%
-16.76M
19.58%
-19.91M
18.82%
-18.22M
8.47%
-25.25M
38.56%
-16.57M
34.36%
-13.37M
19.34%
-13.43M
0.43%
-10.50M
21.78%
investments in property plant and equipment
-574K
-
-108K
81.18%
-170K
57.41%
-438K
157.65%
-114K
73.97%
-378K
231.58%
-254K
32.80%
-771K
203.54%
-333K
56.81%
-509K
52.85%
-170K
66.60%
-316K
85.88%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-574K
-
-108K
81.18%
-170K
57.41%
-438K
157.65%
-114K
73.97%
-378K
231.58%
-254K
32.80%
-771K
203.54%
-333K
56.81%
-509K
52.85%
-170K
66.60%
-316K
85.88%
debt repayment
-71K
-
-28K
60.56%
-21K
25%
-354K
1,585.71%
-688K
94.35%
-22K
96.80%
-21K
4.55%
-21K
0%
-22K
4.76%
-21K
4.55%
-1.69M
7,938.10%
-1.13M
32.94%
-2.24M
98.23%
-1.69M
24.78%
-3.35M
98.70%
common stock issued
140K
-
8K
94.29%
54K
575%
4.31M
7,877.78%
common stock repurchased
4.31M
-
dividends paid
other financing activites
6K
-
153K
2,450%
144.91M
94,613.07%
5K
100.00%
989K
19,680%
115.85M
11,613.65%
16K
99.99%
net cash used provided by financing activities
-65K
-
125K
292.31%
144.89M
115,812.00%
-349K
100.24%
301K
186.25%
115.83M
38,380.40%
-5K
100.00%
-21K
320%
-22K
4.76%
-21K
4.55%
-1.69M
7,938.10%
-992K
41.23%
-2.24M
125.40%
-1.63M
26.92%
954K
158.38%
effect of forex changes on cash
23.19M
-
net change in cash
-11.10M
-
-12.69M
14.31%
121.99M
1,061.43%
-20.92M
117.15%
-20.53M
1.87%
98.29M
578.70%
-21.09M
121.46%
-17.55M
16.81%
-20.26M
15.48%
-18.75M
7.46%
-27.11M
44.55%
-17.88M
34.03%
-15.61M
12.73%
-15.07M
3.44%
-10.72M
28.83%
cash at beginning of period
44.58M
-
33.48M
24.90%
20.79M
37.90%
142.78M
586.78%
121.85M
14.65%
101.32M
16.85%
199.61M
97.01%
178.51M
10.57%
160.96M
9.83%
140.70M
12.59%
121.95M
13.33%
94.84M
22.23%
76.96M
18.86%
59.77M
22.33%
44.70M
25.21%
cash at end of period
33.48M
-
20.79M
37.90%
142.78M
586.78%
121.85M
14.65%
101.32M
16.85%
199.61M
97.01%
178.51M
10.57%
160.96M
9.83%
140.70M
12.59%
121.95M
13.33%
94.84M
22.23%
76.96M
18.86%
61.35M
20.28%
44.70M
27.14%
33.98M
23.99%
operating cash flow
-10.46M
-
-12.71M
21.45%
-22.73M
78.94%
-20.14M
11.43%
-20.72M
2.90%
-17.16M
17.17%
-20.84M
21.40%
-16.76M
19.58%
-19.91M
18.82%
-18.22M
8.47%
-25.25M
38.56%
-16.57M
34.36%
-13.37M
19.34%
-13.43M
0.43%
-10.50M
21.78%
capital expenditure
-574K
-
-108K
81.18%
-170K
57.41%
-438K
157.65%
-114K
73.97%
-378K
231.58%
-254K
32.80%
-771K
203.54%
-333K
56.81%
-509K
52.85%
-170K
66.60%
-316K
85.88%
free cash flow
-11.04M
-
-12.81M
16.11%
-22.90M
78.76%
-20.57M
10.17%
-20.83M
1.26%
-17.54M
15.81%
-21.09M
20.23%
-17.53M
16.89%
-20.24M
15.49%
-18.73M
7.46%
-25.42M
35.70%
-16.89M
33.56%
-13.37M
20.85%
-13.43M
0.43%
-10.50M
21.78%

All numbers in USD (except ratios and percentages)